Columbus Macro LLC Acquires New Stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Columbus Macro LLC bought a new position in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 330,755 shares of the real estate investment trust’s stock, valued at approximately $5,729,000. Columbus Macro LLC owned 0.14% of Sabra Health Care REIT at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of SBRA. Quarry LP bought a new stake in shares of Sabra Health Care REIT during the third quarter valued at about $30,000. Assetmark Inc. raised its holdings in Sabra Health Care REIT by 168.4% in the 3rd quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock worth $37,000 after purchasing an additional 1,231 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in Sabra Health Care REIT in the third quarter worth $59,000. Harbor Capital Advisors Inc. purchased a new position in shares of Sabra Health Care REIT in the 3rd quarter worth about $78,000. Finally, GAMMA Investing LLC boosted its holdings in shares of Sabra Health Care REIT by 25.3% during the 3rd quarter. GAMMA Investing LLC now owns 4,614 shares of the real estate investment trust’s stock valued at $86,000 after acquiring an additional 932 shares during the last quarter. 99.40% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms recently weighed in on SBRA. Truist Financial lowered Sabra Health Care REIT from a “buy” rating to a “hold” rating and decreased their price target for the company from $18.00 to $17.00 in a report on Friday, January 17th. Citizens Jmp raised shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. Scotiabank boosted their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research report on Friday, October 11th. Mizuho reissued a “neutral” rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Finally, JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research note on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Sabra Health Care REIT has a consensus rating of “Moderate Buy” and an average price target of $18.86.

Sabra Health Care REIT Stock Performance

Shares of SBRA opened at $16.91 on Tuesday. The company has a 50-day simple moving average of $17.33 and a two-hundred day simple moving average of $17.62. The firm has a market capitalization of $4.00 billion, a PE ratio of 41.24, a price-to-earnings-growth ratio of 2.01 and a beta of 1.25. Sabra Health Care REIT, Inc. has a one year low of $12.83 and a one year high of $20.03. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.